PHILADELPHIE–(BUSINESS WIRE)–À l’occasion du congrès Clinical Trials Phase I & II A qui s’ouvre aujourd’hui à Philadelphie, le partenariat sans but lucratif CATALIS Québec dévoile une campagne promotionnelle pour faire connaître les atouts du Qué…
Category: Business
The smart choice in early-stage clinical research
PHILADELPHIA–(BUSINESS WIRE)– #ClinicalTrialsQuebec–CATALIS Quebec Clinical Trials demonstrate Quebec’s expertise in early-phase clinical trials. Discover the possibilities: clinicaltrialsquebec.com
Dry Eye Disease (DED) in EU5 (Germany, Spain, Italy, France, UK): Epidemiology Analysis & Forecast 2017-2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Disease (DED) – Epidemiology Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of …
Aura Biosciences Announces Updated Phase 1b/2 Clinical Data for AU-011 Presented at the American Academy of Ophthalmology 2019 Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced the presentation of updated clinical data from its ongoing Phase 1b/2 clinical trial evaluating the safety …
Craig Johnson Has Joined Visioneering Technologies Inc. as Quality Specialist
ATLANTA–(BUSINESS WIRE)–Craig Johnson joined Visioneering Technologies, Inc. in the role of Quality Specialist, based in their Alpharetta, GA Headquarters. Johnson will be responsible for ongoing management of field quality activities including mater…
Avellino Labs Receives CLIA Certification for Its AvaGen Genetic Diagnostic Test for Keratoconus and Corneal Dystrophies
MENLO PARK, Calif.–(BUSINESS WIRE)–Avellino Labs receives CLIA certification for AvaGen genetic diagnostic for keratoconus and corneal dystrophies.
Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.
MUMBAI, India & PRINCETON, N.J.–(BUSINESS WIRE)– #Cequa–Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.
Topcon Healthcare Selected to Ease Transition for IBM® Merge Eye Station and Merge Eye Care PACS Customers
OAKLAND, N.J.–(BUSINESS WIRE)– #AAO–Topcon Healthcare Selected to Ease Transition for IBM Watson Health Imaging Merge Eye Station and Merge Eye Care PACS Customers
PanOptica Anti-VEGF Eye Drop Shows Promise in Treatment of Neovascular (Wet) AMD
MOUNT ARLINGTON, N.J.–(BUSINESS WIRE)–PanOptica reported positive and unprecedented clinical data for PAN-90806, a once-daily topical eye drop, at OIS@AAO.
Aerpio Pharmaceuticals Announces Interim Results from its Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced interim results from its Phase …
La Fondation Tej Kohli prône la mise au point d'une solution technologique abordable, accessible et évolutive pour éradiquer la cécité cornéenne dans le monde entier
LONDRES–(BUSINESS WIRE)–En cette journée mondiale de la vue, la Fondation Tej Kohli fait savoir qu’il est nécessaire d’axer les efforts sur les nouvelles technologies afin d’accélérer la mission internationale dont elle s’est investie, consistant à é…
Eyenuk Receives NIH Grant To Expand AI Eye Screening Platform for Neurodegenerative Disease Detection
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc. has been awarded a grant to develop a retinal image AI solution for the detection of biomarkers for neurodegenerative disorders.
Compulink Launches E-Commerce Solution for its All-in-One Ophthalmology EHR at AAO 2019
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink launches e-commerce solution for its all-in-one ophthalmology EHR at AAO 2019.
For World Sight Day, Horizon and Prevent Blindness Are Calling on the Thyroid Eye Disease (TED) Community to Put “Vision First”
DUBLIN–(BUSINESS WIRE)–For World Sight Day, Horizon Therapeutics and Prevent Blindness are calling on the thyroid eye disease (TED) community to put “vision first.”
Tej Kohli Foundation engagiert sich für eine skalierbare, zugängliche und erschwingliche Technologielösung zur weltweiten Beseitigung der hornhautbedingten Erblindung
LONDON–(BUSINESS WIRE)–Am Welttag des Sehens (World Sight Day) verkündet die Tej Kohli Foundation, dass ein Fokus auf neue Technologien notwendig ist, um die weltweite Mission zur Beseitigung der hornhautbedingten Erblindung verstärkt verfolgen zu kö…
Samenvatting: Tej Kohli Foundation pleit voor een schaalbare, toegankelijke en betaalbare technologie-oplossing voor het beëindigen van hoornvliesblindheid wereldwijd
LONDEN–(BUSINESS WIRE)–Op World Sight Day zegt de Tej Kohli Foundation dat er een focus op nieuwe technologieën nodig is om de wereldwijde missie om een einde te maken aan geneesbare corneale blindheid wereldwijd te versnellen. De Stichting financier…
香港国際オプティカルフェアを11月に開催
香港–(BUSINESS WIRE)–（ビジネスワイヤ） — 第27回HKTDC香港国際オプティカルフェアが、2019年11月6～8日に香港会議展覧中心で開催されます。今年の見本市には、約20の国・地域から約800社が出展します。 世界的広がりを見せる第一級の見本市 今年のフェアでは、フランス、イタリア、日本、韓国、台湾、ビジョナリーズ・オブ・スタイル（VOS）、香港中華眼鏡製造廠商会（HKOMA）によるグループ・パビリオンが開設されます。中国本土のパビリオンには、江西省鷹潭市、江蘇省丹陽市、…
Tej Kohli Foundation advocates a scalable, accessible and affordable technology solution to end corneal blindness worldwide.
LONDON–(BUSINESS WIRE)–On World Sight Day, the Tej Kohli Foundation says that a focus on new technologies is needed to accelerate the global mission to end curable corneal blindness worldwide. The Foundation is currently funding the clinical trials a…
Glaukos Products to be Subject of Multiple Presentations at American Academy of Ophthalmology Annual Meeting
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that …
Kedalion Therapeutics Names New CEO and New Director, Announces Two Promotions, and Will Speak at Ophthalmology Innovation Summit
MENLO PARK, Calif.–(BUSINESS WIRE)–Kedalion Therapeutics names new CEO and new Director, announces two promotions, and will speak at Ophthalmology Innovation Summit